vs
Side-by-side financial comparison of Elme Communities (ELME) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $62.1M, roughly 1.2× Elme Communities). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $7.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 2.7%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ELME vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $75.5M |
| Net Profit | $-123.5M | — |
| Gross Margin | 61.1% | 69.3% |
| Operating Margin | -183.3% | 22.7% |
| Net Margin | -198.9% | — |
| Revenue YoY | 1.7% | 27.7% |
| Net Profit YoY | -4058.7% | — |
| EPS (diluted) | $-1.40 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $62.1M | $54.5M | ||
| Q2 25 | $62.1M | $52.4M | ||
| Q1 25 | $61.5M | $46.0M | ||
| Q4 24 | $61.3M | $59.1M | ||
| Q3 24 | $61.1M | $80.5M | ||
| Q2 24 | $60.1M | $47.1M | ||
| Q1 24 | $59.5M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-123.5M | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-4.7M | $3.0M | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $-3.0M | $20.3M | ||
| Q2 24 | $-3.5M | $-4.5M | ||
| Q1 24 | $-3.6M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 61.1% | 77.7% | ||
| Q2 25 | 63.5% | 76.5% | ||
| Q1 25 | 64.2% | 77.1% | ||
| Q4 24 | 62.9% | 76.4% | ||
| Q3 24 | 63.5% | 63.9% | ||
| Q2 24 | 63.4% | 77.4% | ||
| Q1 24 | 63.5% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -183.3% | 17.6% | ||
| Q2 25 | 9.6% | 12.7% | ||
| Q1 25 | 7.8% | 8.7% | ||
| Q4 24 | 10.4% | 22.6% | ||
| Q3 24 | 11.0% | 27.4% | ||
| Q2 24 | 9.8% | -4.6% | ||
| Q1 24 | 7.5% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -198.9% | 16.2% | ||
| Q2 25 | -5.7% | 11.2% | ||
| Q1 25 | -7.6% | 6.5% | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | -4.9% | 25.2% | ||
| Q2 24 | -5.8% | -9.6% | ||
| Q1 24 | -6.1% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-1.40 | $0.17 | ||
| Q2 25 | $-0.04 | $0.12 | ||
| Q1 25 | $-0.05 | $0.06 | ||
| Q4 24 | $-0.04 | $0.40 | ||
| Q3 24 | $-0.03 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.04 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $908.9M | $130.3M |
| Total Assets | $1.7B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $7.1M | $94.4M | ||
| Q2 25 | $4.8M | $96.0M | ||
| Q1 25 | $6.4M | $93.2M | ||
| Q4 24 | $6.1M | $101.0M | ||
| Q3 24 | $4.8M | $96.7M | ||
| Q2 24 | $5.6M | $96.8M | ||
| Q1 24 | $4.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $908.9M | $115.3M | ||
| Q2 25 | $1.0B | $104.7M | ||
| Q1 25 | $1.1B | $97.1M | ||
| Q4 24 | $1.1B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.1B | $48.5M | ||
| Q1 24 | $1.1B | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.8B | $194.9M | ||
| Q1 25 | $1.8B | $196.2M | ||
| Q4 24 | $1.8B | $213.3M | ||
| Q3 24 | $1.9B | $220.7M | ||
| Q2 24 | $1.9B | $205.0M | ||
| Q1 24 | $1.9B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $14.4M |
| Free Cash FlowOCF − Capex | $7.2M | $14.4M |
| FCF MarginFCF / Revenue | 11.6% | 19.1% |
| Capex IntensityCapex / Revenue | 14.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $15.9M | $9.7M | ||
| Q2 25 | $29.8M | $14.1M | ||
| Q1 25 | $16.2M | $3.6M | ||
| Q4 24 | $95.2M | $15.6M | ||
| Q3 24 | $20.7M | $11.0M | ||
| Q2 24 | $28.9M | $1.0M | ||
| Q1 24 | $21.2M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $7.2M | $9.7M | ||
| Q2 25 | $21.1M | $14.1M | ||
| Q1 25 | $10.5M | $3.6M | ||
| Q4 24 | $47.9M | $15.6M | ||
| Q3 24 | $8.8M | $11.0M | ||
| Q2 24 | $21.0M | $1.0M | ||
| Q1 24 | $7.6M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | 11.6% | 17.7% | ||
| Q2 25 | 34.1% | 26.8% | ||
| Q1 25 | 17.1% | 7.7% | ||
| Q4 24 | 78.1% | 26.4% | ||
| Q3 24 | 14.4% | 13.7% | ||
| Q2 24 | 34.9% | 2.1% | ||
| Q1 24 | 12.8% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 14.0% | 0.0% | ||
| Q2 25 | 14.0% | 0.0% | ||
| Q1 25 | 9.2% | 0.1% | ||
| Q4 24 | 77.4% | 0.0% | ||
| Q3 24 | 19.4% | 0.0% | ||
| Q2 24 | 13.1% | 0.0% | ||
| Q1 24 | 22.9% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
PBYI
Segment breakdown not available.
